Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection

Israel Medical Association Journal

Volumn 3, Issue 6, 2001, Pages 451-452

  Gilad, Jacob ^a   Borer, Abraham ^a   Hallel Halevy, Dafna ^a   Riesenberg, Klaris ^a   Alkan, Michael ^a   Schlaeffer, Francisc ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Dermal leishmaniasis; Highly active anti retroviral therapy; Human immunodeficiency virus; Immune reconstitution; Kala azar

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; STIBOGLUCONATE SODIUM; VIRUS RNA; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE DURATION; ETHIOPIA; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMIGRANT; IMMUNE SYSTEM; ISRAEL; LEISHMANIA; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PATIENT REFERRAL; RASH; SKIN BIOPSY; VISCERAL LEISHMANIASIS;

ADULT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE;

EID: 0035717323     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Effect of HAART on natural history of AIDS-related opportunistic disorders
2. Endemic kala-azar in eastern Sudan. Post-kala-azar dermal leishmaniasis
3. Post-kala-azar dermal leishmaniasis in the Sudan: Clinical presentation and differential diagnosis
4. Post-kala-azar dermal leishmaniasis in an HIV-patient
5. Clinicoepidemiologic characteristics, prognostic factors and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain